Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01697059 · ClinicalTrials.gov registry record · NA
Initial Antibiotics and Delayed Appendectomy for Acute Appendicitis
A NA study of Acute Appendicitis, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
- 1
- Study location
NCT01697059 is a NA study of Acute Appendicitis that has completed, run by Rhode Island Hospital. The registered enrollment target is 73 participants, below the 875-participant average among 4 other Acute Appendicitis trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01697059, a NA study of Acute Appendicitis, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
- 1
- Study location
Study Summary
Several recent studies have examined the feasibility and benefits of nonoperative treatment of perforated appendicitis in children. One such study showed a trend toward longer operative times for patients randomized to immediate appendectomy, but no overall advantage. In another larger study, the costs of delayed appendectomy for perforated appendicitis were higher - in part related to readmissions in the interval (6-8 weeks). Nevertheless, these and other studies have demonstrated the safety of delaying appendectomy for perforated appendicitis. Emergency appendectomy is a well-established approach, and postoperative recovery in children is fast. Nevertheless, from the onset of symptoms through the hospital stay and the postoperative recovery, appendicitis causes a disruption of a family's normal routine (absence from school and work) of up to 1-2 weeks. Because this is an unplanned operation, patients have to wait until an operating room becomes available, or elective operations have to be placed on hold to accommodate the emergency operation. Each year, more than 250 children undergo an appendectomy at HCH. This represents 250 episodes of emergency surgery, or about one emergency add-on operation per working day. If an initial trial of antibiotics is safe for the treatment of appendicitis, converting an emergency operation into an elective, scheduled outpatient procedure may reduce stress and disruption of routine for patients and their families - and may allow better operating room planning for health care professionals and hospitals. The investigators hypothesize that initial antibiotic treatment of acute (non-perforated) appendicitis, followed by scheduled outpatient appendectomy, reduces the overall cost of treating the disease and results in greater patient and family satisfaction. This pilot study aims to establish the safety and feasibility of treating acute appendicitis with intravenous antibiotics, followed by outpatient oral antibiotics. Patients and
Conditions Studied
Interventions
- DRUG Piperacillin + Amoxicillin
Study Locations (1)
Rhode Island
- Hasbro Children's Hospital (Rhode Island Hospital) - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2012-09 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01697059
The ClinicalTrials.gov registry entry for NCT01697059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 875-participant average among 4 other Acute Appendicitis trials with a reported enrollment target (92% lower). The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Appendicitis appearing as the primary indexed condition, and to 1 intervention - of which Piperacillin + Amoxicillin is the first listed.
NCT01697059 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01697059 about?
NCT01697059 is a clinical study titled "Initial Antibiotics and Delayed Appendectomy for Acute Appendicitis". Several recent studies have examined the feasibility and benefits of nonoperative treatment of perforated appendicitis in children. One such study showed a trend toward longer operative times for patients randomized to immediate appendectomy, but no overall advantage. In another larger study, the co...
What is the current status of trial NCT01697059?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2012-09. Estimated completion is 2015-05.
What conditions does trial NCT01697059 study?
This clinical trial studies the following conditions: Acute Appendicitis.
What interventions are being tested in trial NCT01697059?
The interventions under investigation include: Piperacillin + Amoxicillin (DRUG).
Who is sponsoring clinical trial NCT01697059?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01697059 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Appendicitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Retrospective Acute Care Appendectomy Study
RECRUITING
-
The Role of Contrast Enhanced Ultrasound in Appendicitis
COMPLETED · Phase 2
-
The Performance of the APPY1 Test in the Evaluation of Possible Acute Appendicitis
COMPLETED
-
Point of Care Ultrasound for Evaluation of Suspected Appendicitis in the Emergency Department
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.